Towards the optimal vector for prostate cancer gene therapy; a CaPCURE meeting report

Marianne G. Rots; David T. Curiel

doi:10.1038/sj.cgt.7700253

Towards the optimal vector for prostate cancer gene therapy; a CaPCURE meeting report

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1507-1510
Number of pages	4
Journal	Cancer gene therapy
Volume	7
Issue number	12
DOIs	https://doi.org/10.1038/sj.cgt.7700253
State	Published - 2000

Keywords

Oncolysis
Prostate cancer
Targeting
Transgene

Access to Document

10.1038/sj.cgt.7700253

Cite this

@article{ddb8a32a292f4b5b85181202f3818612,

title = "Towards the optimal vector for prostate cancer gene therapy; a CaPCURE meeting report",

keywords = "Oncolysis, Prostate cancer, Targeting, Transgene",

author = "Rots, {Marianne G.} and Curiel, {David T.}",

note = "Funding Information: The authors thank Ramon Alemany, Candace Coolidge, and Jesus Gomez-Navarro for critically reading the manuscript. CaPCURE is acknowledged for organizing this meeting as well as for realizing important research in the area of prostate cancer therapy. All presenters are thanked for their presentation and useful comments of this manuscript. This work is supported by the following grants: National Institute of Health R01 CA83821, U.S. Department of Defense PC970193, U.S. Department of Defense PC 991018, and the CaPCURE Foundation.",

year = "2000",

doi = "10.1038/sj.cgt.7700253",

language = "English",

volume = "7",

pages = "1507--1510",

journal = "Cancer gene therapy",

issn = "0929-1903",

number = "12",

}

TY - JOUR

T1 - Towards the optimal vector for prostate cancer gene therapy; a CaPCURE meeting report

AU - Rots, Marianne G.

AU - Curiel, David T.

N1 - Funding Information: The authors thank Ramon Alemany, Candace Coolidge, and Jesus Gomez-Navarro for critically reading the manuscript. CaPCURE is acknowledged for organizing this meeting as well as for realizing important research in the area of prostate cancer therapy. All presenters are thanked for their presentation and useful comments of this manuscript. This work is supported by the following grants: National Institute of Health R01 CA83821, U.S. Department of Defense PC970193, U.S. Department of Defense PC 991018, and the CaPCURE Foundation.

PY - 2000

Y1 - 2000

KW - Oncolysis

KW - Prostate cancer

KW - Targeting

KW - Transgene

UR - http://www.scopus.com/inward/record.url?scp=0034490393&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7700253

DO - 10.1038/sj.cgt.7700253

M3 - Comment/debate

C2 - 11228528

AN - SCOPUS:0034490393

SN - 0929-1903

VL - 7

SP - 1507

EP - 1510

JO - Cancer gene therapy

JF - Cancer gene therapy

IS - 12

ER -

Towards the optimal vector for prostate cancer gene therapy; a CaPCURE meeting report

Keywords

Access to Document

Other files and links

Cite this